Showing 9221-9230 of 21415 results for "".
AI in Point-of-Care Ultrasound: Balancing Innovation With Clinical Judgment
https://reachmd.com/programs/clinicians-roundtable/ai-pocus-innovation-clinical-judgment/54227/AI is rapidly becoming part of point-of-care ultrasound, but relying on its output without verification can lead to significant interpretation errors. Join Dr. Taro Minami as he examines where AI can support image acquisition and quantitative assessment and where it can fall short. Dr. Minami is theExploring Sub-Ablative Radiation to Modulate Immunity in Mesothelioma
https://reachmd.com/programs/project-oncology/sub-ablative-radiation-modulate-immunity-mesothelioma/39983/Could lower doses of radiation help optimize immune response in mesothelioma? Dr. John Cho joins us to explain how tailoring radiation to a tumor’s inflammatory and immunogenic characteristics could help modulate antitumor immunity while reducing the potential for fibrosis and treatment-related toxiThe Importance of Skin Barrier Repair in Atopic Dermatitis
https://reachmd.com/programs/practical-dermatology-updates-in-atopic-dermatitis/the-importance-of-skin-barrier-repair-in-atopic-dermatitis/57284/Naeim T. Issa, MD, PhD, FAAD, explains why patients with atopic dermatitis are notoriously barrier deficient and how aryl hydrocarbon receptor agonists can help address that issue.Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
https://reachmd.com/programs/on-the-frontlines-of-attr-cm/early-detection-attr-cm-clinical-clues-imaging/49041/Identifying key cardiac and extracardiac red flags is essential in diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) early. Dr. Shelina Ramnarine is joined by Dr. Valmiki Maharaj to review the diagnostic pathway and explore how we can recognize ATTR-CM earlier in the disease course.Managing Partial Response in IBS-C Care
https://reachmd.com/programs/clinicians-roundtable/managing-partial-response-ibs-c/51042/Irritable bowel syndrome with constipation (IBS-C) often presents with persistent symptoms despite initial therapy, requiring a more comprehensive approach to assessment and management. As a result, clinicians must evaluate global symptom burden, quality of life, and patient preferences to determineAthlete-Focused CPET: Interpreting Physiology Beyond Standardized Testing
https://reachmd.com/programs/heart-matters/athlete-cpet-beyond-standardized-testing/54807/Cardiopulmonary exercise testing (CPET) provides critical insights into athletic performance when tailored to the individual and their sport-specific demands. Dr. Benjamin Levine shares insights on how to interpret key metrics and why customized testing approaches are so important in this populatioSurgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
https://reachmd.com/programs/project-oncology/surgery-gastroesophageal-cancer-surveillance-intervention/49171/For patients with locally advanced gastroesophageal cancer, surgery remains a critical component of curative treatment—even in the era of chemoradiation and advanced imaging. Dr. Daniela Molena explores the challenges of assessing complete clinical response and the risks of non-operative managemUsing fMRI to Identify Early Alzheimer’s Disease Subgroups
https://reachmd.com/programs/neurofrontiers/fmri-early-alzheimers-subgroups/40003/Preclinical Alzheimer’s disease presents a unique challenge due to its silent progression and biological complexity. However, emerging data highlights the role of brain connectivity in distinguishing patient subtypes before clinical symptoms arise. Join Dr. Hamid Abuwarda as he discusses how functioIdentifying Mpox Hospitalization Risks in Patients with HIV During the 2022 Outbreak
https://reachmd.com/programs/clinicians-roundtable/identifying-mpox-hospitalization-risks-in-patients-with-hiv-during-the-2022-outbreak/32853/During the 2022 mpox outbreak, New York City emerged as the epicenter, with disproportionate impacts on gay and bisexual men. A new study presented at IDWeek 2025 examines how HIV-related factors, such as CD4 count, ART status, and syphilis co-infection, shaped mpox severity and hospitalization riskPrevention on the Horizon: Early Intervention and Risk Reduction in MS Care
https://reachmd.com/programs/frontlines-multiple-sclerosis/prevention-on-the-horizon-early-intervention-and-risk-reduction-in-ms-care/36389/Understanding and identifying early risk factors for multiple sclerosis (MS) is critical to shifting care toward prevention and minimizing long-term disease burden. Ashley Baker sits down with Dr. Vikram Bhise to discuss how emerging biomarkers and updated diagnostic criteria could enable earlier in